Disease-associated marked hyperalphalipoproteinemia

Molecular Genetics and Metabolism Reports

Volumn 1, Issue 1, 2014, Pages 264-268

  Hirano, Ken Ichi ^a   Nagasaka, Hironori ^b   Kobayashi, Kazuhiro ^c   Yamaguchi, Satoshi ^a   Suzuki, Akira ^a   Toda, Tatsushi ^c   Doyu, Manabu ^d  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TAKARAZUKA CITY HOSPITAL   (Japan)

^c KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; Cardiovascular disease; Cholesteryl ester transfer protein deficiency; High density lipoprotein; Hyperalphalipoproteinemia; Stroke

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CHOLESTERYL ESTER TRANSFER PROTEIN DEFICIENCY; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERALPHALIPOPROTEINEMIA; HYPERLIPOPROTEINEMIA; JAPAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NEOPLASM; PATHOPHYSIOLOGY; PROTEIN DEFICIENCY; SEX DIFFERENCE; CORONARY RISK; DIABETES MELLITUS; EXON; GENE MUTATION; HETEROZYGOTE; HOMOZYGOTE; HYPERTENSION; LONGEVITY; MISSENSE MUTATION; PREVALENCE; SMOKING;

EID: 84905164067     PISSN: None     EISSN: 22144269     Source Type: Journal    
DOI: 10.1016/j.ymgmr.2014.06.001     Document Type: Article

References (22)

1. Y. Matsuzawa, S. Yamashita, K. Kameda, M. Kubo, S. Tarui, and I. Hara Marked hyper-HDL2-cholesterolemia associated with premature corneal opacity. A case report Atherosclerosis 53 1984 207 212 (http://www.ncbi.nlm.nih.gov/pubmed/ 6517975) (Pubitemid 15209461)
2. J. Koizumi, H. Mabuchi, A. Yoshimura, I. Michishita, M. Takeda, H. Itoh, Y. Sakai, T. Sakai, K. Ueda, and R. Takeda Deficiency of serum cholesteryl-ester transfer activity in patients with familial hyperalphalipoproteinaemia Atherosclerosis 58 1985 175 186 (http://www.ncbi.nlm.nih.gov/pubmed/3937535) (Pubitemid 16173307)
3. S. Yamashita, Y. Matsuzawa, M. Okazaki, H. Kako, T. Yasugi, H. Akioka, K. Hirano, and S. Tarui Small polydisperse low density lipoproteins in familial hyperalphalipoproteinemia with complete deficiency of cholesteryl ester transfer activity Atherosclerosis 70 1988 7 12 (http://www.ncbi.nlm.nih.gov/pubmed/ 3355618) (Pubitemid 18091697)
4. A.R. Tall Plasma cholesteryl ester transfer protein J. Lipid Res. 34 1993 1255 1274 (http://www.ncbi.nlm.nih.gov/pubmed/8409761) (Pubitemid 23230305)
5. A. Inazu, M.L. Brown, C.B. Hesler, L.B. Agellon, J. Koizumi, K. Takata, Y. Maruhama, H. Mabuchi, and A.R. Tall Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation N. Engl. J. Med. 323 1990 1234 1238 10.1056/NEJM199011013231803 (Pubitemid 20366528)
6. C.J. Fielding, and R.J. Havel Cholesteryl ester transfer protein: friend or foe? J. Clin. Invest. 97 1996 2687 2688 10.1172/JCI118719 (Pubitemid 26197083)
7. K. Hirano, S. Yamashita, Y. Kuga, N. Sakai, S. Nozaki, S. Kihara, T. Arai, K. Yanagi, S. Takami, and M. Menju et al. Atherosclerotic disease in marked hyperalphalipoproteinemia. Combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase Arterioscler. Thromb. Vasc. Biol. 15 1995 1849 1856 (http://www.ncbi.nlm.nih.gov/pubmed/7583564)
8. K. Hirano, S. Yamashita, and Y. Matsuzawa Pros and cons of inhibiting cholesteryl ester transfer protein Curr. Opin. Lipidol. 11 2000 589 596 (http://www.ncbi.nlm.nih.gov/pubmed/11086331)
9. P.J. Barter, and K.A. Rye Cholesteryl ester transfer protein inhibition as a strategy to reduce cardiovascular risk J. Lipid Res. 53 2012 1755 1766 10.1194/jlr.R024075
10. K. Hirano, S. Yamashita, N. Nakajima, T. Arai, T. Maruyama, Y. Yoshida, M. Ishigami, N. Sakai, K. Kameda-Takemura, and Y. Matsuzawa Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity Arterioscler. Thromb. Vasc. Biol. 17 1997 1053 1059 (http://www.ncbi.nlm.nih.gov/pubmed/9194754) (Pubitemid 27260323)
11. T. Maruyama, N. Sakai, M. Ishigami, K. Hirano, T. Arai, S. Okada, E. Okuda, A. Ohya, N. Nakajima, K. Kadowaki, E. Fushimi, S. Yamashita, and Y. Matsuzawa Prevalence and phenotypic spectrum of cholesteryl ester transfer protein gene mutations in Japanese hyperalphalipoproteinemia Atherosclerosis 166 2003 177 185 (http://www.ncbi.nlm.nih.gov/pubmed/12482565) (Pubitemid 35449614)
12. M. Nagano, S. Yamashita, K. Hirano, M. Takano, T. Maruyama, M. Ishihara, Y. Sagehashi, T. Kujiraoka, K. Tanaka, H. Hattori, N. Sakai, N. Nakajima, T. Egashira, and Y. Matsuzawa Molecular mechanisms of cholesteryl ester transfer protein deficiency in Japanese J. Atheroscler. Thromb. 11 2004 110 121 (http://www.ncbi.nlm.nih.gov/pubmed/15256762)
13. K. Saito, K. Kobori, H. Hashimoto, S. Ito, M. Manabe, and S. Yokoyama Epitope mapping for the anti-rabbit cholesteryl ester transfer protein monoclonal antibody that selectively inhibits triglyceride transfer J. Lipid Res. 40 1999 2013 2021 (http://www.ncbi.nlm.nih.gov/pubmed/10553005) (Pubitemid 29523428)
14. A. Goto, K. Sasai, S. Suzuki, T. Fukutomi, S. Ito, T. Matsushita, M. Okamoto, T. Suzuki, M. Itoh, K. Okumura-Noji, and S. Yokoyama Cholesteryl ester transfer protein and atherosclerosis in Japanese subjects: a study based on coronary angiography Atherosclerosis 159 2001 153 163 (http://www.ncbi.nlm.nih. gov/pubmed/11689217) (Pubitemid 33016632)
15. M. Okazaki, S. Usui, A. Fukui, I. Kubota, and H. Tomoike Component analysis of HPLC profiles of unique lipoprotein subclass cholesterols for detection of coronary artery disease Clin. Chem. 52 2006 2049 2053 10.1373/clinchem.2006.070094 (Pubitemid 44658206)
16. M. Ishigami, S. Yamashita, N. Sakai, T. Arai, K. Hirano, H. Hiraoka, K. Kameda-Takemura, and Y. Matsuzawa Large and cholesteryl ester-rich high-density lipoproteins in cholesteryl ester transfer protein (CETP) deficiency can not protect macrophages from cholesterol accumulation induced by acetylated low-density lipoproteins J. Biochem. 116 1994 257 262 (http://www.ncbi.nlm.nih. gov/pubmed/7822240) (Pubitemid 24265594)
17. N. Sakai, S. Yamashita, K. Hirano, M. Ishigami, T. Arai, K. Kobayashi, T. Funahashi, and Y. Matsuzawa Decreased affinity of low density lipoprotein (LDL) particles for LDL receptors in patients with cholesteryl ester transfer protein deficiency Eur. J. Clin. Invest. 25 1995 332 339 (http://www.ncbi.nlm.nih.gov/ pubmed/7628520)
18. S. Zhong, D.S. Sharp, J.S. Grove, C. Bruce, K. Yano, J.D. Curb, and A.R. Tall Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels J. Clin. Invest. 97 1996 2917 2923 10.1172/JCI118751 (Pubitemid 26197108)
19. J.P. Corsetti, W. Zareba, A.J. Moss, D.L. Rainwater, and C.E. Sparks Elevated HDL is a risk factor for recurrent coronary events in a subgroup of non-diabetic postinfarction patients with hypercholesterolemia and inflammation Atherosclerosis 187 2006 191 197 10.1016/j.atherosclerosis.2005.09.012 (Pubitemid 43817014)
20. T. Costacou, R.W. Evans, and T.J. Orchard High-density lipoprotein cholesterol in diabetes: is higher always better? J. Clin. Lipidol. 5 2011 387 394 10.1016/j.jacl.2011.06.011
21. W. Plengpanich, W. Le Goff, S. Poolsuk, Z. Julia, M. Guerin, and W. Khovidhunkit CETP deificiency due to a novel mutation in the CETP gene promoter and its effect on cholesterol efflux and selective uptake into hepatocytes Atherosclerosis 216 2011 370 373 10.1016/j.atherosclerosis.2011.01.051 (Epub 2011 Feb 26)
22. P.E. Khoury, W. Plengpanich, E. Frisdal, W. Le Goff, W. Khovidhunkit, and M. Guerin Improved plasma cholesterol efflux capacity from human macrophages in patients with hyperalphalipoproteinemia Atherosclerosis 234 2014 193 199 10.1016/j.atherosclerosis.2014.02.032 (Epub 2014 Mar 12)